Diagnosis and treatment of primary amyloidosis.
Pascali
E
E
Institute of General Clinical Medicine, University of Trieste, Cattinara Hospital, Italy.
D000210:Acute-Phase Reaction; D000328:Adult; D000368:Aged; D000682:Amyloid / Q000145:classification / Q000378:metabolism; D000686:Amyloidosis / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D001402:B-Lymphocytes / Q000378:metabolism / Q000473:pathology; D001706:Biopsy; D002648:Child; D000075202:Contraindications; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007150:Immunohistochemistry; D007596:Joints / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009420:Nervous System / Q000473:pathology; D010265:Paraproteinemias / Q000150:complications / Q000378:metabolism / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D017582:Renal Replacement Therapy; D012867:Skin / Q000473:pathology; D013194:Staining and Labeling; D014781:Viscera / Q000473:pathology
D000682:Amyloid; D007136:Immunoglobulins; D008558:Melphalan; D011241:Prednisone